Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PNP | P00491 | 2/20 | 0.70 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | THRB | P10828 | 1/20 | 0.49 |
| ▸ | HPGD | P15428 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.49 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.44 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.44 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.44 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.44 |
| ▸ | XDH | P47989 | 3/20 | 0.40 |
| ▸ | GDA | Q9Y2T3 | 1/20 | 0.40 |
| ▸ | DPP4 | P27487 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Guanine SCHEMBL27594331 | 0.94 | PNP (0.62) | PNPALDH1A1KDM4EMEN1MAPT | |
| Guanine SCHEMBL16552675 | 0.94 | PNP (0.62) | PNPALDH1A1KDM4EMEN1MAPT | |
| Guanine SCHEMBL3820889 | 0.93 | PNP (0.60) | PNPALDH1A1KDM4EMEN1MAPT | |
| Guanine SCHEMBL28064900 | 0.91 | PNP (0.58) | PNPALDH1A1KDM4EMEN1MAPT | |
| 8-Azaguanine SCHEMBL3953066 | 0.86 | PNP (0.51) | PNPALDH1A1KDM4EMEN1MAPT | |
| Guanine SCHEMBL30814355 | 0.85 | PNP (0.96) | PNPALDH1A1KDM4EMEN1MAPT | |
| Guanine SCHEMBL8008324 | 0.84 | PNP (0.50) | PNPALDH1A1KDM4EMEN1MAPT | |
| Guanine SCHEMBL18154053 | 0.84 | PNP (0.50) | PNPALDH1A1KDM4EMEN1MAPT | |
| Guanine SCHEMBL5260 | 0.84 | PNP (1.00) | PNPALDH1A1KDM4EMEN1MAPT | |
| Guanine SCHEMBL1264884 | 0.84 | PNP (1.00) | PNPALDH1A1KDM4EMEN1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 214 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023241051-A1 | FLUORESCENTLY LABELED COMPOSITE SGRNA, AND PREPARATION METHOD THEREFOR AND USE THEREOF | 图维生物医药科技(苏州)有限公司 | 2023-12-21 | — | — | WO | claimed |
| US-20240226275-A1 | COMPOSITIONS AND METHODS OF MRNA VACCINES AGAINST NOVEL CORONAVIRUS INFECTION | RNAimmune, Inc. (US) | 2024-07-11 | — | — | US | disclosed |
| CN-118302181-A | Multigang TP53 and PAN-RAS mRNA cancer vaccine | 达冕生物有限公司 | 2024-07-05 | — | — | CN | disclosed |
| EP-4388017-A1 | COMPOSITIONS AND METHODS FOR ANTI-VIRUS CHIMERIC ANTIGEN RECEPTOR | Rudd, Christopher E. (CA) | 2024-06-26 | — | — | EP | disclosed |
| EP-4384214-A2 | COMPOSITION AND METHODS OF MRNA VACCINES AGAINST NOVEL CORONAVIRUS INFECTION | Rnaimmune, Inc. (US) | 2024-06-19 | — | — | EP | disclosed |
| CN-118119930-A | Compositions and methods for mRNA vaccines against novel coronavirus infection | 达冕生物有限公司 | 2024-05-31 | — | — | CN | disclosed |
| US-20240156947-A1 | COMPOSITION AND METHODS FOR MRNA VACCINES AGAINST NOVEL OMICRON CORONAVIRUS INFECTIONS | RNAimmune, Inc. (US) | 2024-05-16 | — | — | US | disclosed |
| WO-2024097894-A1 | COMPOSITIONS AND METHODS OF RIBONUCLEIC ACID VACCINES ENCODING NYE-SO-1 | RNAimmune, Inc. (US) | 2024-05-10 | — | — | WO | disclosed |
| WO-2024097259-A1 | COMPOSITION AND METHODS FOR MRNA VACCINES AGAINST NOVEL OMICRON CORONAVIRUS INFECTIONS | RNAimmune, Inc. (US) | 2024-05-10 | — | — | WO | disclosed |
| EP-4351615-A2 | MULTIPLEXED TP53 AND PAN-RAS MRNA CANCER VACCINES | Rnaimmune, Inc. (US) | 2024-04-17 | — | — | EP | disclosed |
| EP-0472498-A1 | Monoclonal antibodies to leptosphaeria | CIBA-GEIGY AG (CH) | 1992-02-26 | — | — | EP | disclosed |
| EP-0465415-A2 | Monoclonal antibodies to mycosphaerella species | CIBA-GEIGY AG (CH) | 1992-01-08 | — | — | EP | disclosed |
| US-4879217-A | MONOCLONAL ANTIBODIES FOR IMMUNOASSAY | AGRI-DIAGNOSTICS ASSOCIATES (US) | 1989-11-07 | — | — | US | disclosed |
| US-4845197-A | IMMUNOLOGICAL DETECTION OF FUNGAL PLANT DISEASES | AGRI-DIAGNOSTICS ASSOCIATES (US) | 1989-07-04 | — | — | US | disclosed |
| US-4803155-A | DETECTION OF PATHOGENIC FUNGUS IN TURFGRASS, USING AN ANALYTICALLY DETECTABLE LABELLED ANTIBODY-ANTIGEN COMPLEX | AGRI-DIAGNOSTICS ASSOCIATES (US) | 1989-02-07 | — | — | US | disclosed |
| EP-0292719-A2 | A test for rhizoctonia brown and yellow patch | DNAP DIAGNOSTICS, INC. (a Delaware corporation) (US) | 1988-11-30 | — | — | EP | disclosed |
| EP-0234501-A2 | Monocional antibodies and methods for fungal pathogen detection | DNAP DIAGNOSTICS, INC. (a Delaware corporation) (US) | 1987-09-02 | — | — | EP | disclosed |
| EP-0222998-A2 | Monoclonal antibodies and methods for fungal pathogen detection | DNAP DIAGNOSTICS, INC. (a Delaware corporation) (US) | 1987-05-27 | — | — | EP | disclosed |
| US-4564597-A | Anti-Sm hybridoma | RESEARCH CORPORATION (US) | 1986-01-14 | — | — | US | disclosed |
| US-4246408-A | Imidazo[1,2-a]-s-triazine | ICN PHARMACEUTICALS (US) | 1981-01-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240156947-A1 | COMPOSITION AND METHODS FOR MRNA VACCINES AGAINST NOVEL OMICRON CORONAVIRUS INFECTIONS | RBM22, RNGTT, RBM25 | PNP 200/4885ALDH1A1 4880/4885KDM4E 4620/4885 |
| US-20240226275-A1 | COMPOSITIONS AND METHODS OF MRNA VACCINES AGAINST NOVEL CORONAVIRUS INFECTION | RNGTT, SARS1, ACE2 | PNP 241/4885ALDH1A1 4884/4885KDM4E 4697/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.